Synacthen, Injektionslösung

7680317230012 CH-31723 Injektionslösung
Synacthen, Injektionslösung
Synacthen, Injektionslösung
Synacthen, Injektionslösung
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/11/2023
Summary of Product Characteristics
Français
13/11/2023
Summary of Product Characteristics
Italien
13/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.34 MG Substance HBESI

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
31723
Drug name
Synacthen, Injektionslösung
Galenic form
LSIN
ATC Code
H01AA02
Authorization status
Z
Dispensing category
B
First authorization
18/11/1965
Authorization expiration date
31/12/9999
IT Number
07.07.1.
Domain
Human medicine
Field of application
Funktionsdiagnostik der NNR; ACTH-Therapie

Package details

Description (FR)
SYNACTHEN 0.25 mg/ml i.m./i.v. amp 1 ml
Description (DE)
SYNACTHEN 0.25 mg/ml i.m./i.v. Amp 1 ml
Market launch
18/11/1965
Narcotic (BTM)
No

Other package sizes (1)

SYNACTHEN sol inj 0.25 mg/ml i.m./i.v. 10 amp 1 ml
None None
GTIN: 7680317230272
Not in V1